Evidence map›Paper›PMID 34638845›Full record

ArticleInternational journal of molecular sciences2021

Helium Conditioning Increases Cardiac Fibroblast Migration Which Effect Is Not Propagated via Soluble Factors or Extracellular Vesicles.

Marek Jelemenský, Csenger Kovácsházi, Kristína Ferenczyová, Monika Hofbauerová, Bernadett Kiss, Éva Pállinger, Ágnes Kittel, Viktor Nabil Sayour, Anikó Görbe, Csilla Pelyhe and 6 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marek JelemenskýInstitute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Csenger KovácsháziDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Kristína FerenczyováInstitute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Monika HofbauerováInstitute of Physics, Slovak Academy of Sciences, Dúbravská Cesta 9, 84511 Bratislava, Slovakia.ORCID 0000-0003-3309-128X
Bernadett KissDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Éva PállingerDepartment of Genetics, Cell and Immunobiology, Semmelweis University, 1089 Budapest, Hungary.
Ágnes KittelInstitute of Experimental Medicine, Eötvös Loránd Research Network, 1083 Budapest, Hungary.
Viktor Nabil SayourDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Anikó GörbeDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Csilla PelyheDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0001-6267-4527
Szabolcs HambalkóDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0003-3638-0394
Lucia KindernayInstitute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Miroslav BarančíkInstitute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Péter FerdinandyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
Monika BartekováInstitute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.ORCID 0000-0002-5210-5184
Zoltán GiriczDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0003-2036-8665

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-18-0548Emberi Eroforrások Minisztériuma ÚNKP-18-4-E-17Emberi Eroforrások Minisztériuma ÚNKP-19-4-SE-94Innovációs és Technológiai Minisztérium 2020-4.1.1.-TKP2020Innovációs és Technológiai Minisztérium Doctoral Student Scholarship Program of the Co-operative Doctoral ProgramMagyar Tudományos Akadémia János Bolyai Research ScholarshipNemzeti Kutatási Fejlesztési és Innovációs Hivatal NVKP-16-1-2016-0017Slovak Academic Information Agency National Scholarship ProgrammeSlovenská Akadémia Vied VEGA no. 2/0104/20
6 · The paper itself

Abstract

Helium inhalation induces cardioprotection against ischemia/reperfusion injury, the cellular mechanism of which remains not fully elucidated. Extracellular vesicles (EVs) are cell-derived, nano-sized membrane vesicles which play a role in cardioprotective mechanisms, but their function in helium conditioning (HeC) has not been studied so far. We hypothesized that HeC induces fibroblast-mediated cardioprotection via EVs. We isolated neonatal rat cardiac fibroblasts (NRCFs) and exposed them to glucose deprivation and HeC rendered by four cycles of 95% helium + 5% CO

Indexed as

AnimalsAnimals, NewbornCell-Derived MicroparticlesCell LineCell MovementCells, CulturedCulture Media, ConditionedFibroblastsHeliumHumansHuman Umbilical Vein Endothelial CellsMaleMicroscopy, Electron, TransmissionMyocardiumNeovascularization, PhysiologicRatsCulture Media, ConditionedHeliumangiogenesisendothelial cellextracellular vesiclesfibroblasthearthelium conditioningHUVECmicrovesiclesmigrationNRCF

Identifiers

PMID34638845
PMCPMC8508629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.